TMCNet:  Research and Markets: Global In-Vitro Diagnostics (IVD) Market Forecasts and Opportunities, 2020

[September 02, 2014]

Research and Markets: Global In-Vitro Diagnostics (IVD) Market Forecasts and Opportunities, 2020

DUBLIN --(Business Wire)--

Research and Markets ( has announced the addition of the "Global In Vitro Diagnostics (IVD) Market - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020" report to their offering.

The various segments studied in the report include techniques, product, usability, applications, end-user, and geography. Point of care technique of diagnosis is identified as the most popular technique amongst the physicians, clinicians and doctors. It accounted for about 31.0% of the overall IVD market in 2013, and is expected to grow at a CAGR of 3.5% during the forecast period. Major factor contributing for this growth is convenience provided by POC diagnostic devices over conventional diagnostics devices.

Instruments, reagents, data management software, and services are studied as the major segments of the global IVD product market of which instruments segment is expected to be the largest revenue-generating segment through 2020. Global IVD market, by usability of diagnostic devices, is classified as disposable and reusable devices. Due to the cost effectiveness and reusability of the devices for multi patient testing, re-usable devices segment holds the lead position; however, disposable devices segment is catching up rapidly at much faster rates.

The global market for In Vitro Diagnostics, by application, is segmented into infectious disease, diabetes, cancer, cardiology, autoimmune diseases, nephrology, drug testing, and HIV/AIDS of which diagnosis of infectious disease is the most attractive application market followed by HIV/AIDS. Increase in the number of incidences of such diseases is primary driver for faster adoption of IVD techniques in these applications.

Hospitals, laboratories, academics, point of care testing are the major end use segments analyzed in the report and laboratory segment is identified to be the largest end-use segment. Point of care technique provides convenience in diagnosis of disease at home thus it is projected to emerge out as the fastest growing market during the forecast period. The top global market players and their growth strategies are also discussed in this study. Product launch, acquisitions, approvals for various products are some major strategies adopted by the market players to maintain their positions in the competitive environment.

The report showcases top players such as:

  • Abbot Laboratories
  • Roche Diagnostics
  • Siemens
  • Johnson & Johnson
  • Alere Inc
  • Arkray Inc
  • Bayer AG
  • Becton Dickinson & Company
  • Biomerieux
  • Dahaner Corporation
  • Sysmex Corp


  • Immunoassays
  • Clinical Chemistry
  • Point Of Care
  • Molecular Diagnostics
  • Hematology
  • Coagulation
  • Microbiology
  • Other clinical techniques


  • Instruments
  • Reagents
  • Data management systems
  • Services


  • Disposable
  • Reusable


  • Infectious Diseases
  • Diabetes
  • Cancer/Oncology
  • Cardiology
  • Autoimmune Diseases
  • Nephrology
  • Drug Testing


  • Hospitals
  • Laboratories
  • Academics
  • Point of Care Testing
  • Others

For more information visit

[ Back To NFVZone's Homepage ]